At Bluestone Pharma®, we are dedicated to improving health with a strong focus on the human oral microbiome. Our mission is to develop and manufacture innovative and clinical efficacious probiotic formulas using proprietary technology and strong clinical evidence. This ensures that our partners gain a competitive edge in the probiotic market, driving their success.
Bactoblis®, our flagship probiotic, is the most clinically tested formula for recurrent respiratory infections in children and teenagers, backed by over 30 clinical studies.
Since our founding in 2013, we have expanded into 25 countries, with healthcare professionals prescribing over 200 million doses of our products globally.
Company Details
- Employees
- 8
- Founded
- 2013
- Address
- Rathausstr. 14, Baar,6340,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bluestone-pharma.com
- Keywords
- Pharmaceuticals, Healthcare, Probiotics, Finished Products, Oral Probiotics, medical probiotics, innovation, manufacturing, probiotic lozenges.
- HQ
- Baar
Bluestone Pharma Questions
Bluestone Pharma's website is bluestone-pharma.com
Bluestone Pharma's LinkedIn profile is https://ch.linkedin.com/company/bluestone-pharma
Bluestone Pharma has
8 employees.
View email and phone details for 8
employees at Bluestone Pharma.
Bluestone Pharma's industry is
Biotechnology Research
Bluestone Pharma's top competitors are
Wecare Probiotics Co., Ltd.,
Iprona Group,
Pharmextracta Spa,
Esn,
Ab-Biotics,
Medico Domus,
Biotical Health.,
Hech Europe Gmbh,
Akay Bioactives,
Roelmi Hpc - Società Benefit.
Bluestone Pharma's categories are Biotechnology Research
Bluestone Pharma's founding year is 2013
